Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
M.D. Anderson Cancer Center
University of Chicago
Tianjin Medical University Cancer Institute and Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
H. Lee Moffitt Cancer Center and Research Institute
Mayo Clinic
National Cancer Institute (NCI)
Abramson Cancer Center at Penn Medicine
Dana-Farber Cancer Institute
Shandong Cancer Hospital and Institute
Tata Memorial Centre
University College, London
Xi'an Jiaotong University
University Medical Center Groningen
EMD Serono
Obstetrics & Gynecology Hospital of Fudan University
First Affiliated Hospital of Guangxi Medical University
University Hospital, Toulouse
Peking Union Medical College Hospital
Ruijin Hospital
AIDS Malignancy Consortium
Peking Union Medical College Hospital
Abramson Cancer Center at Penn Medicine
Zhejiang Cancer Hospital
Sun Yat-sen University
Sichuan University
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Witwatersrand, South Africa
Leo W. Jenkins Cancer Center
Zhejiang Cancer Hospital
Asan Medical Center
University of Miami
European Organisation for Research and Treatment of Cancer - EORTC
Alliance for Clinical Trials in Oncology
European Organisation for Research and Treatment of Cancer - EORTC
Wenzhou Medical University
Wenzhou Medical University
GOG Foundation
Radiation Therapy Oncology Group
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
GOG Foundation
GOG Foundation